Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 13, 2026

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

7.6K

Small Cell Lung Cancer.

Gregory P Kalemkerian1

  • 1Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan.

Seminars in Respiratory and Critical Care Medicine
|October 13, 2016
PubMed
Summary
This summary is machine-generated.

Small cell lung cancer (SCLC) is a deadly neuroendocrine tumor. Treatment involves chemotherapy and radiation, with prophylactic cranial irradiation potentially improving survival for limited-stage SCLC patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Pembrolizumab in Combination With Platinum-Based Chemotherapy in Patients With Recurrent EGFR and ALK Gene Altered Non-Small-Cell Lung Cancer (NSCLC).

Clinical lung cancer·2025
Same author

The Art of the Art of Oncology.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Epidemiology of SCLC in the United States From 2000 to 2019: A Study Utilizing the Surveillance, Epidemiology, and End Results Registry.

JTO clinical and research reports·2025
Same author

Erratum: Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update Clinical Insights.

JCO oncology practice·2025
Same author

Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same journal

Monographic Issue on New Concepts in Acute Exacerbations of COPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Bidirectional Clinical Interactions among Exacerbations and Comorbidities in COPD: A Narrative Review.

Seminars in respiratory and critical care medicine·2026
Same journal

Radiological Approach to Severe Respiratory Infections and Pulmonary Complications in Immunocompromised Patients.

Seminars in respiratory and critical care medicine·2026
Same journal

Two Sides of the Same Smoke: Decoding Respiratory Bronchiolitis-Associated Interstitial Lung Disease and Alveolar Macrophage Pneumonia.

Seminars in respiratory and critical care medicine·2026
Same journal

Role of Vaccination in the Prevention of ECOPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives.

Seminars in respiratory and critical care medicine·2026
See all related articles

Area of Science:

  • Oncology
  • Medical Imaging
  • Radiation Oncology

Background:

  • Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor with high mortality.
  • SCLC is characterized by rapid growth and early metastasis, necessitating accurate staging and treatment planning.
  • While chemotherapy and radiation offer survival benefits, long-term cures remain rare.

Purpose of the Study:

  • To review current diagnostic and therapeutic strategies for SCLC.
  • To highlight the role of imaging in SCLC management.
  • To discuss the efficacy of different treatment modalities for limited-stage and extensive-stage SCLC.

Main Methods:

  • Review of current literature on SCLC diagnosis and treatment.
  • Discussion of the impact of positron emission tomography (PET) in staging and treatment planning.

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

Related Experiment Videos

Last Updated: Mar 13, 2026

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

7.6K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K
  • Analysis of chemotherapy regimens, radiation therapy techniques (including hyperfractionated and sequential), and prophylactic cranial irradiation (PCI).

    • Main Results:

    • PET imaging enhances accuracy in SCLC staging and treatment planning.
    • Limited-stage SCLC (LS-SCLC) offers a potential cure with platinum-based chemotherapy and thoracic radiation, with survival rates of 20-25%.
    • Hyperfractionated radiation and PCI may improve survival in selected LS-SCLC patients, while PCI and sequential radiation show promise in extensive-stage SCLC (ES-SCLC).

    Conclusions:

    • SCLC treatment remains challenging, with limited progress in systemic therapies over decades.
    • Future SCLC advancements hinge on developing targeted therapies addressing molecular drivers of proliferation, survival, and immune evasion.
    • Integrated treatment strategies combining chemotherapy, radiation, and novel molecularly targeted approaches are crucial for improving patient outcomes.